In summarizing the results presented in this Research Topic, the advent of liquid biopsy has revolutionized the diagnosis and management of bladder cancers. It offers non-invasive and sensitive molecular approaches to detect the onset and progression of the disease and unravel complex molecular dynamics. Bladder cancer is a globally prevalent disease that affects both sexes but is more common in men than women (1 in 28 men, 1 in 89 women). Due to the high recurrence rate, two major challenges are early detection of asymptomatic forms and precise clinical treatment, for which prognostic molecular markers and targets are of fundamental importance. In this context, several recent studies, including Li et al., Wang et al., Yang et al., and Synelnyk have contributed significantly to our understanding of biomarkers useful for the diagnosis and prognosis of bladder cancer, as well as the new insights into the application of liquid biopsy.

Liquid biopsy in the detection and prediction of outcomes in bladder cancer

Bruna Scaggiante
Writing – Review & Editing
2024-01-01

Abstract

In summarizing the results presented in this Research Topic, the advent of liquid biopsy has revolutionized the diagnosis and management of bladder cancers. It offers non-invasive and sensitive molecular approaches to detect the onset and progression of the disease and unravel complex molecular dynamics. Bladder cancer is a globally prevalent disease that affects both sexes but is more common in men than women (1 in 28 men, 1 in 89 women). Due to the high recurrence rate, two major challenges are early detection of asymptomatic forms and precise clinical treatment, for which prognostic molecular markers and targets are of fundamental importance. In this context, several recent studies, including Li et al., Wang et al., Yang et al., and Synelnyk have contributed significantly to our understanding of biomarkers useful for the diagnosis and prognosis of bladder cancer, as well as the new insights into the application of liquid biopsy.
2024
Pubblicato
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1391466/full
File in questo prodotto:
File Dimensione Formato  
Editorial Frontiers.pdf

accesso aperto

Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 781.06 kB
Formato Adobe PDF
781.06 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3070181
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact